Kabiven Peripheral (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The mixture provides the nine essential amino acids required for protein synthesis. Delivered directly into the bloodstream, these amino acids become building blocks for new proteins, support tissue repair, and help preserve lean body mass while maintaining nitrogen equilibrium in patients receiving total parenteral nutrition.

The dose is individualized and set by the prescribing clinician based on the patient’s weight, clinical condition, nitrogen requirements, and laboratory values. Healthcare professionals calculate the appropriate volume and infusion rate to meet each patient’s specific nutritional needs.

Safety data in pregnancy and lactation are limited. Kabiven Peripheral should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Kabiven Peripheral offers a balanced profile of essential amino acids comparable to other commercial parenteral amino acid formulations. Differences among products may include concentration, osmolarity, and specific amino‑acid ratios, which can affect compatibility with other IV fluids and the choice of infusion site.

Store Kabiven Peripheral at 2‑8 °C, protected from light. Do not freeze or shake the container. Keep the solution in its original packaging until use and discard any product that appears discolored or has particulate matter.

Kabiven Peripheral is administered intravenously, typically through a peripheral or central venous catheter. The solution may be diluted according to the manufacturer’s instructions, and the infusion rate is set by the clinician based on the patient’s prescribed daily amino‑acid requirement.

Serious risks include anaphylactic reactions, severe metabolic disturbances such as metabolic acidosis or hypernatremia, and hepatic dysfunction. Prompt recognition and medical intervention are essential if any of these severe adverse events occur.

Kabiven Peripheral should be avoided in patients with known hypersensitivity to any of its amino‑acid components, severe hepatic failure, uncontrolled metabolic disorders, or in situations where the risk of amino‑acid overload outweighs the nutritional benefit.